Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR
Part of paid clinical trials in Oak Lawn, Illinois.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT06376916
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Atrial Fibrillation
- Atrial Flutter With Rapid Ventricular Response
- Tachycardia Atrial
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Magnesium Sulfate 2 G — DRUGMagnesium Sulfate 2g for the treatment of atrial fibrillation or atrial flutter with rapid ventricular response (AFF RVR)
- Magnesium Sulfate 4 G — DRUGMagnesium Sulfate 4g for the treatment of atrial fibrillation or atrial flutter with rapid ventricular response (AFF RVR)
- Saline — DRUGThe control group will receive a bolus of normal saline of the same volume and infused over 15 minutes.
Study Details
The purpose of this prospective, randomized, double-blinded study is to further evaluate the safety and efficacy of varying doses of intravenous magnesium in the treatment of AFF RVR.
Key Dates
- Start date
- Oct 7, 2024
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 153 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Experimental Arm One, Magnesium Sulfate 2gStudy drug (Magnesium Sulfate 2 gram/50ml 0.9% NaCl)
- Experimental: Experimental Arm Two, Magnesium Sulfate 4gMagnesium Sulfate 4g/50ml 0.9% NaCl
- Placebo Comparator: Control Arm, normal saline50ml 0.9% NaCl
Primary Outcome Measure
Ventricular rate control [ Time Frame: Within the first 2 hours of intravenous magnesium administration ]
Central Contacts
- Marc McDowell, PharmD(708) 684-1078
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Advocate Christ Medical Center Emergency Department (ACMC ED) | Oak Lawn | Illinois | 60453 |
Find similar trials in Oak Lawn, IL
By condition
By specialty
Related Studies
- Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial FibrillationPHASE4 · Recruiting · University of Illinois at Chicago · Chicago, Illinois
- CardioFocus HeartLight Post-Approval StudyRecruiting · CardioFocus · Tucson, Arizona
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- The CONFORM Pivotal TrialRecruiting · Conformal Medical, Inc · Birmingham, Alabama